First Trust Nasdaq Pharmaceuticals ETF (FTXH)
Description
The investment seeks to track the performance of the Nasdaq US Smart Pharmaceuticals Index. The FTXH ETF contains 29 constituents. It is focused on blend holdings in the North America region.
Price $24.63 as of 2022-10-20Cost/Risk/Yield
| Dividend yield | 1.17% |
| Expense ratio | 0.6% |
| Average spread | 0.487% |
| 1Y roundtrip cost | 1.087% |
Historic prices
Total Returns (including dividends)
Monthly returns heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | -4.7% | -1.9% | 5.4% | -1.6% | 1.5% | -0.4% | 0.2% | -6.1% | -3.0% | 2.5% | -8.1% | ||
| 2021 | 1.3% | -1.2% | -0.6% | 1.2% | -0.3% | 0.5% | 2.0% | 1.1% | -3.2% | 1.7% | -2.9% | 6.7% | 6.3% |
| 2020 | -1.9% | -8.4% | -7.0% | 15.1% | 2.1% | 0.0% | 5.3% | 3.3% | -2.5% | -4.5% | 8.7% | 3.4% | 13.5% |
| 2019 | 6.1% | 7.1% | -2.0% | -2.0% | -4.9% | 6.4% | -2.5% | -1.6% | 0.6% | 3.8% | 7.9% | 2.3% | 21.2% |
| 2018 | 5.1% | -3.9% | -2.6% | 0.2% | 1.7% | 1.6% | 5.6% | 3.5% | -0.9% | -7.2% | -0.4% | -11.3% | -8.5% |
| 2017 | 2.3% | 6.7% | -0.7% | 0.3% | -0.5% | 4.8% | -1.7% | -3.6% | 3.9% | -3.6% | 7.8% | 2.9% | 18.7% |
| 2016 | -8.2% | 3.0% | -1.4% | -6.7% | |||||||||
| 8.1% | -1.6% | -7.5% | 13.2% | -0.4% | 12.9% | 8.9% | -3.4% | -5.0% | -15.5% | 24.0% | 2.6% |
Historical Dividends
Monthly dividend heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | 0.05 | 0.04 | 0.09 | 0.18 | |||||||||
| 2021 | 0.08 | 0.05 | 0.04 | 0.11 | 0.28 | ||||||||
| 2020 | 0.06 | 0.05 | 0.04 | 0.06 | 0.21 | ||||||||
| 2019 | 0.03 | 0.04 | 0.05 | 0.04 | 0.16 | ||||||||
| 2018 | 0.08 | 0.04 | 0.03 | 0.04 | 0.18 | ||||||||
| 2017 | 0.03 | 0.06 | 0.38 | 0.47 | |||||||||
| 2016 | 0.03 | 0.03 | |||||||||||
| 0.00 | 0.00 | 0.32 | 0.00 | 0.00 | 0.27 | 0.00 | 0.00 | 0.63 | 0.00 | 0.00 | 0.29 |
Sectors and Top Holdings
| Security | % Assets |
|---|---|
| Merck & Co., Inc. | 9.17% |
| Prestige Consumer Healthcare Inc | 8.35% |
| Pfizer Inc. | 7.84% |
| Johnson & Johnson | 7.60% |
| AbbVie, Inc. | 7.40% |
| Horizon Therapeutics Public Limited Company | 4.31% |
| Catalent Inc | 4.15% |
| Zoetis, Inc. Class A | 4.12% |
| Eli Lilly and Company | 3.95% |
| BioMarin Pharmaceutical Inc. | 3.92% |
| Alkermes Plc | 3.77% |
| Cardinal Health, Inc. | 3.70% |
| Gilead Sciences, Inc. | 3.60% |
| United Therapeutics Corporation | 3.55% |
| Bristol-Myers Squibb Company | 3.48% |
| Top 15 Weights | 78.91% |
Compare with similar ETFs
| FTXH | MFMS | PBE | PJUN | PPH | SNUG | |
|---|---|---|---|---|---|---|
| Product name | First Trust Nasdaq Pharmaceuticals ETF | Motley Fool Small-Cap Growth ETF | PowerShares Dynamic Biotechnology & Genome Portfolio ETF | Innovator S&P 500 Power Buffer ETF June Series | Market Vectors Pharmaceutical ETF | Merlyn.AI Tactical Growth and Income ETF |
| Issuer | First Trust | Motley Fool | Invesco | Innovator | VanEck | Merlyn.AI |
| Price | $24.63 | $23.0353 | $59.39 | $28.766 | $68.21 | $23.055 |
| Expense Ratio | 0.6% |  0.85% |  0.59% | 0.79% | 0.35% | 0.88% |
| Average Spread | 0.487% | 0.781% | 0.253% | 0.313% | 0.044% | 0.304% |
| AUM | $15,923,000 | $102,411,000 | $226,683,000 | $137,882,000 | $296,076,000 | $19,591,900 |
| Shares | 646,487 | 4,445,828 | 3,816,854 | 4,793,233 | 4,340,652 | 849,788 |
| Average Daily Volume | 13,172 | 7,625 | 8,743 | 31,457 | 171,153 | 2,643 |
| Home page | Visit external site | Visit external site | Visit external site | Visit external site | Visit external site | Visit external site |
| Inception Date | 2016-09-20 | 2018-10-23 | 2005-06-23 | 2019-06-03 | 2000-02-01 | 2020-02-24 |
| Index Tracked | Nasdaq US Smart Pharmaceuticals Index | No Underlying Index | Dynamic Biotechnology & Genome Intellidex Index | No Underlying Index | MVIS U.S. Listed Pharmaceutical 25 Index | MAI Tactical Growth and Income Index |
| Category | Health & Biotech Equities | Small Cap Growth Equities | Health & Biotech Equities | Volatility Hedged Equity | Health & Biotech Equities | Diversified Portfolio |
| Asset Class | Equity | Equity | Equity | Equity | Equity | Multi-Asset |
| Asset Class Size | Large/Mid Caps | Mid/Small Caps | Large/Mid/Small Caps | Large/Mid Caps | ||
| Value or Growth | Blend | Growth | Growth | Blend | Blend | Blend |
| Region | North America | North America | North America | North America | North America | |
| Countries | U.S. | U.S. | U.S. | U.S. | Broad | U.S. |
| Annual Dividend Rate | $0.288 | $0 | $0 | $0 | $1.232 | $0.214 |
| Annual Dividend Yield | 0.012% | 0.000% | 0.000% | 0.000% | 0.018% | 0.009% |
| Number of Holdings | 29 | 30 | 30 | 0 | 25 | |
| YTD Return | -8.34% | -36.91% | -16.60% | -10.73% | -10.22% | -16.98% |
| Beta | 0.92 | 1.00 | 1.22 | 0.46 | 0.80 | 0.39 |
| Upside Beta | 0.64 | 0.36 | 0.12 | 0.25 | 0.12 | 0.23 |
| Downside Beta | 0.19 | 0.36 | 0.09 | 0.22 | 0.24 | -0.33 |
| Volatility 1Y | 18.52% | 30.68% | 30.04% | 10.43% | 16.98% | 11.80% |
| Sharpe Ratio 3Y | 0.47 | -0.08 | 0.31 | 0.17 | 0.57 | 0.00 |
| Treynor Ratio 3Y | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |